Glioblastoma multiforme MRI: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Glioblastoma multiforme}} {{CMG}} ==MRI== <div align="left"> <gallery heights="175" widths="175"> Image:Glioblastoma - MR sagittal with contrast.jpg|Image 1b. Sagittal [[M...")
 
No edit summary
 
(37 intermediate revisions by 7 users not shown)
Line 1: Line 1:
__NOTOC__
{{Glioblastoma multiforme}}
{{Glioblastoma multiforme}}
{{CMG}}  
{{CMG}}{{AE}}{{SR}}
 
==Overview==
Brain MRI is helpful in the diagnosis of glioblastoma multiforme. On brain MRI, glioblastoma multiforme is characterized by a butterfly shaped mass, which is hypointense on T1-weighted [[MRI]] and hyperintense on T2-weighted MRI.


==MRI==
==MRI==
<div align="left">
Brain MRI is helpful in the diagnosis of glioblastoma multiforme. On brain [[MRI]], glioblastoma multiforme is characterized by:
<gallery heights="175" widths="175">
 
Image:Glioblastoma - MR sagittal with contrast.jpg|Image 1b. Sagittal [[MRI]] with contrast of a glioblastoma WHO grade IV in a 15-year-old boy
[[File:Glioblastoma-GIF1.gif|thumb|200px|sagital section of brain showing Glioblastoma multiforme  [https://upload.wikimedia.org/wikipedia/commons/b/b2/Animazione_RMN_saggittale_dopo_rimozione_glioblastoma.gif Source:Wikimedia Commons] ]]
Image:Glioblastoma - MR coronal with contrast.jpg|Image 1a. Coronal [[MRI]] with contrast of a glioblastoma WHO grade IV in a 15-year-old boy
 
</gallery>
[[File:GlioblastomaGIF2.gif|thumb|200px|Transverse section of brain showing Glioblastoma multiforme  [https://upload.wikimedia.org/wikipedia/commons/c/ce/Animazione_RMN_trasversale_dopo_rimozione_glioblastoma.gif Source:Wikimedia Commons] ]]
</div>
 
[[File:Glioblastoma multiforme - MRi.jpg|thumb|200px|Transverse section of brain showing Glioblastoma multiforme  [https://upload.wikimedia.org/wikipedia/commons/0/0f/Glioblastoma_multiforme_-_MRT_T2_ax.jpg Source:Wikimedia Commons] ]]
 
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align="center"
| valign="top" |
|+
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|MRI component}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Features}}
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
:T1
| style="padding: 5px 5px; background: #F5F5F5;" |
*Butterfly shaped mass
*Hypo to isointense mass within [[white matter]]
*Central heterogenous signal ([[necrosis]], intratumoral [[hemorrhage]])
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
:T1 C+ (Gd)
| style="padding: 5px 5px; background: #F5F5F5;" |
*Enhancement is variable
*Typically peripheral and irregular with [[nodular]] components
*Usually completely surrounds [[necrosis]]
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
:T2/FLAIR
| style="padding: 5px 5px; background: #F5F5F5;" |
*Hyperintense
*Surrounded by vasogenic [[edema]]
*Flow voids
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
:GE/SWI
| style="padding: 5px 5px; background: #F5F5F5;" |
*Susceptibility artifact on T2 from blood products (or occasionally [[calcification]])
*Low intensity rim from blood product
*Located inside the peripheral enhancing component
*Absent dual rim sign
|-
| rowspan="3" style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |DWI/ADC
| style="padding: 5px 5px; background: #F5F5F5;" |
*Solid component
:* Elevated signal on DWI is common in solid / enhancing component
:* Diffusion restriction is typically intermediate similar to normal [[white matter]], but significantly elevated compared to surrounding vasogenic [[edema]] (which has facilitated diffusion)
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
* ADC values correlate with grade:
:* WHO IV (GBM) = 745 ± 135 x 10-6 mm2/s
:* WHO III (anaplastic) = 1067 ± 276 x 10-6 mm2/s
:* WHO II (low grade) = 1273 ± 293 x 10-6 mm2/s
:* ADC threshold value of 1185 x 10-6 mm2/s sensitivity (97.6%) and specificity (53.1%) in the discrimination of high-grade (WHO grade III & IV) and low-grade (WHO grade II) gliomas
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
* Non-enhancing necrotic / cystic component
:* Majority (>90%) have facilitated diffusion (ADC values > 1000 x 10-6 mm2/s)
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
:MR perfusion
| style="padding: 5px 5px; background: #F5F5F5;" |
*rCBV elevated compared to lower grade [[tumors]] and normal [[brain]]
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
:MR spectroscopy
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Choline]]: increased
*[[Lactate]]: increased
*[[Lipids]]: increased
*[[N-Acetylaspartate|NAA]]: decreased
*[[Myo-inositol]]: decreased
|-
|}
 
<div align="left"></div>


==References==
==References==
{{reflist|2}}
[[Category:Neurosurgery]]
[[Category:Neurosurgery]]
[[Category:Neurology]]
[[Category:Neurology]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Oncology]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
<references />

Latest revision as of 23:33, 15 April 2019

Glioblastoma multiforme Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Glioblastoma multiforme from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Glioblastoma multiforme MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Glioblastoma multiforme MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Glioblastoma multiforme MRI

CDC on Glioblastoma multiforme MRI

Glioblastoma multiforme MRI in the news

Blogs on Glioblastoma multiforme MRI

Directions to Hospitals Treating Glioblastoma multiforme

Risk calculators and risk factors for Glioblastoma multiforme MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Brain MRI is helpful in the diagnosis of glioblastoma multiforme. On brain MRI, glioblastoma multiforme is characterized by a butterfly shaped mass, which is hypointense on T1-weighted MRI and hyperintense on T2-weighted MRI.

MRI

Brain MRI is helpful in the diagnosis of glioblastoma multiforme. On brain MRI, glioblastoma multiforme is characterized by:

sagital section of brain showing Glioblastoma multiforme Source:Wikimedia Commons
Transverse section of brain showing Glioblastoma multiforme Source:Wikimedia Commons
Transverse section of brain showing Glioblastoma multiforme Source:Wikimedia Commons
MRI component Features
T1
T1 C+ (Gd)
  • Enhancement is variable
  • Typically peripheral and irregular with nodular components
  • Usually completely surrounds necrosis
T2/FLAIR
  • Hyperintense
  • Surrounded by vasogenic edema
  • Flow voids
GE/SWI
  • Susceptibility artifact on T2 from blood products (or occasionally calcification)
  • Low intensity rim from blood product
  • Located inside the peripheral enhancing component
  • Absent dual rim sign
DWI/ADC
  • Solid component
  • Elevated signal on DWI is common in solid / enhancing component
  • Diffusion restriction is typically intermediate similar to normal white matter, but significantly elevated compared to surrounding vasogenic edema (which has facilitated diffusion)
  • ADC values correlate with grade:
  • WHO IV (GBM) = 745 ± 135 x 10-6 mm2/s
  • WHO III (anaplastic) = 1067 ± 276 x 10-6 mm2/s
  • WHO II (low grade) = 1273 ± 293 x 10-6 mm2/s
  • ADC threshold value of 1185 x 10-6 mm2/s sensitivity (97.6%) and specificity (53.1%) in the discrimination of high-grade (WHO grade III & IV) and low-grade (WHO grade II) gliomas
  • Non-enhancing necrotic / cystic component
  • Majority (>90%) have facilitated diffusion (ADC values > 1000 x 10-6 mm2/s)
MR perfusion
  • rCBV elevated compared to lower grade tumors and normal brain
MR spectroscopy

References


Template:WikiDoc Sources